Departments of Animal Science & Physiology
Dr. Cibelli currently holds the position of Professor of Animal Biotechnology at Michigan State University. He heads the Cellular Reprogramming Laboratory in the Departments of Animal Science and Physiology since 2003. Since 2010 he is also the Scientific Director of LARCel, a laboratory of cellular reprogramming dedicated to generate human pluripotent cells under GMP conditions for preclinical studies in Andalucia, Spain. From October 1999 until December 2002 he was the vice president for research of Advanced Cell Technology, a stem cell company in Worcester, Massachusetts.
Dr. Cibelli is internationally recognized as one of the pioneers in the area of cellular reprogramming using oocyte-driven protocols. Dr. Cibelli together with his colleagues, were responsible for the generation of the world's first transgenic cloned calves, the first stem cells by nuclear transfer in bovine, the first embryonic stem cells by parthenogenesis in primates and the generation of the first cell line of iPSCs using oocyte factors alone. His work has been published un numerous scientific journals including Science, Nature Biotechnology, Nature Medicine, Nature Methods, PNAS, Cell Stem Cell and JAMA. He has testified about his work in public forums sponsored by the US Food and Drug administration, the USA National Academy of Sciences, Canadian House of Commons, the USA Department of Agriculture, the United Nations Commission for Human Rights and the British Royal Society.
Dr. Cibelli is also the Associate Director of the Andalucian Program of Advanced Therapies also in Spain, a government sponsored program running clinical trials in cell therapy under guidelines from the National and European Medicine Agencies. He is also a Member of the External Scientific Committee for Research of the Andalucian BIOBANK, a government-run repository of biological samples used on biomedical research, and a Member of Scientific Advisory Committee for the Center for Embryonic Cell and Gene Therapy at Oregon Health & Science University, Portland, Oregon. He serves as a Trustee of the Bedford Stem Cell Research Foundation and has served in the International Committee of the 'International Stem Cell Research Society', the Ethics Committee of the 'American Society of Gene and Cell Therapy' and the Scientific and Medical Accountability Standards Working Group of the 'California Institute for Regenerative Medicine'.
In 1998 he graduated from the University of Massachusetts-Amherst with a PhD in Reproductive Biology, and in 1989 from Universidad de La Plata, Buenos Aires, Argentina with a DVM degree.